Liomont

Liomont is a wholly Mexican pharmaceutical company founded in 1938, with 88 years of experience developing, manufacturing, and commercializing medicines intended to help relieve human suffering. The company describes scientific research, technological development, and high-quality production as central to its work, and has grown into a prominent participant in Mexico’s pharmaceutical industry. Its products include prescription medicines and over-the-counter treatments for a range of health needs, including pain relief, colds, and weight management.

Liomont also invests in advanced biotechnology, including monoclonal antibodies, biosimilars, and other biotechnological solutions, as well as research and production of biotechnological vaccines. Its three specialized manufacturing plants produce sterile medicines, biotechnological products, and generics under international quality, safety, and regulatory standards. The company reports commercial presence in 16 markets across the Americas and Europe.

Alongside its product portfolio, Liomont provides pharmacovigilance reporting for possible adverse reactions and highlights commitments to innovation, health-system capacity, social responsibility, and accessible medicines. Ongoing investments in infrastructure, talent, and technology support its long-term focus on healthcare